Advanced Modalities
Company Overview
About
Ikarovec is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:United Kingdom
Founded:2013
Employees:1,577
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval D4L8P0
Health Canada · #APR-65NGBU17 · 2018-08-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
WHO GMP
World Health Organization
Cert #: CERT-HYAQGDRU
Issued: 2020-04-04
Expires: 2025-05-19
Health Canada GMP
Health Canada
Cert #: CERT-WE2N2NU2
Issued: 2020-09-01
Expires: 2025-02-07
Loading CDMO intelligence...
Key facts about Ikarovec
- Ikarovec is headquartered in the United Kingdom.
- Ikarovec was founded in 2013.
- Ikarovec has 1,577 employees.
- Ikarovec's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Ikarovec
Directory pages this company appears in, each with the full list of matching manufacturers.